neutral
2 days agoTop Brokerage Radar: Lenskart, Global Health and Teamlease Receive Fresh Analyst Calls
Ahead of Monday’s session, several domestic and global brokerages issued new updates on Swiggy, Lenskart, Global Health and Teamlease, adjusting their outlooks and share price targets. Jefferies maintained its buy rating on Lenskart with a ₹500 target, noting that the company has entered a strong compounding phase driven by technology enhancements and supply chain efficiencies.
Explore:High Return Equity Mutual Fund
neutral
2 days agoTop Brokerage Radar: Lenskart, Global Health and Teamlease Receive Fresh Analyst Calls
Ahead of Monday’s session, several domestic and global brokerages issued new updates on Swiggy, Lenskart, Global Health and Teamlease, adjusting their outlooks and share price targets. Jefferies maintained its buy rating on Lenskart with a ₹500 target, noting that the company has entered a strong compounding phase driven by technology enhancements and supply chain efficiencies.
Explore:High Return Equity Mutual Fund
Recently
1 min read
56 words
Lenskart, Global Health and Teamlease drew fresh brokerage attention, with Jefferies reaffirming a buy on Lenskart and analysts updating targets across multiple companies.
Ahead of Monday’s session, several domestic and global brokerages issued new updates on Swiggy, Lenskart, Global Health and Teamlease, adjusting their outlooks and share price targets. Jefferies maintained its buy rating on Lenskart with a ₹500 target, noting that the company has entered a strong compounding phase driven by technology enhancements and supply chain efficiencies.
Ahead of Monday’s session, several domestic and global brokerages issued new updates on Swiggy, Lenskart, Global Health and Teamlease, adjusting their outlooks and share price targets. Jefferies maintained its buy rating on Lenskart with a ₹500 target, noting that the company has entered a strong compounding phase driven by technology enhancements and supply chain efficiencies.
Dec 1, 2025 • 04:35